Long-acting beta2-agonists for chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Long-acting beta2-agonists for chronic obstructive pulmonary disease

Published:2013-10-15 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kew Kayleigh M¹,Mavergames Chris²,Walters Julia AE³

Affiliation:

1. St George's, University of London; Population Health Sciences and Education; Cranmer Terrace London UK SW17 0RE

2. The Cochrane Collaboration; Based at The German Cochrane Centre Berliner Allee 29 Freiburg Germany 79110

3. University of Tasmania; School of Medicine; MS1, 17 Liverpool Street PO Box 23 Hobart Tasmania Australia 7001

Publisher

Wiley

Subject

Pharmacology (medical)

Reference279 articles.

1. Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial;Aalbers;European Respiratory Journal,2002

2. Sybrecht GW Inhaled formoterol was an effective and safe treatment in COPD patients European Respiratory Society; 1999 October 9-13; Madrid, p 2510

3. Efficacy and safety of inhaled formoterol 4.5 and 9 microg twice daily in Japanese and European COPD patients: Phase III study results;Bogdan;BMC Pulmonary Medicine,2011

4. Efficacy and safety of inhaled formoterol 4.5 and 9 1/4g twice daily in Japanese and European patients with COPD: results of a Phase III study [Abstract];Bogdan;American Journal of Respiratory and Critical Care Medicine,2010

5. Ichinose M Aizawa H Fukuchi Y Mishima M Nishimura M Bogdan M Patient-reported outcomes (PROs) and reliever use in Japanese and European patients with chronic obstructive pulmonary disease receiving formoterol 4.5 and 9 microg twice daily: Results of the OCEAN phase III study [Abstract] European Respiratory Society Annual Congress; 2010 Sep 18-22; Barcelona, p 4591

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Change is in the air: key questions on the ‘Treatable Traits’ model for chronic airway diseases in primary care;npj Primary Care Respiratory Medicine;2024-07-18

2. Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease;Archivos de Bronconeumología;2024-04

3. The Effectiveness and Safety of Chuna Manual Therapy Adjuvant to Western Medicine in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Single-Blind, Investigator-Initiated, Pilot Trial;Healthcare;2024-01-09

4. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2023-12-06

5. Association between use of transdermal tulobuterol and short-term outcomes in patients with stroke and underlying chronic obstructive pulmonary disease: A retrospective cohort study;Medicine;2023-09-22